Choosing the wrong penetration testing vendor is an expensive mistake in healthcare. You pay for an assessment, you hand over a report to an auditor or a customer, and only later do you discover it was a lightly rebranded vulnerability scan that missed the authorization flaw an attacker later walked straight through. In a sector where a breach means reportable PHI exposure, regulatory scrutiny, and lost trust, the quality of your tester matters as much as the test itself.
This guide is written for the person doing the comparison: the CISO, the compliance lead, or the founder who has three proposals on the desk and needs to tell them apart. Below are seven questions that separate a serious healthcare penetration testing company from a commodity scanner, the red flags that should give you pause, and what good answers actually sound like. Use them on every shortlisted vendor, including us.
Healthcare is not a generic testing target. A qualified tester needs to understand PHI data flows, the HIPAA Security Rule, clinical systems such as EHRs and PACS, and interoperability protocols like HL7 and FHIR. They also need to work safely around systems where downtime affects patient care. A generalist firm that treats a hospital like any other corporate network will miss healthcare-specific exposure and may handle sensitive systems carelessly.
The questions below are designed to surface that depth, or its absence, before you sign. The right answers are not about buzzwords. They are about evidence: certifications you can verify, sample work you can read, and a methodology the vendor can explain in plain terms.
Certifications are not everything, but they are a useful floor, especially hands-on, practical ones. Ask specifically which individual testers will work on your engagement and what they hold. For technical penetration testing, look for practical, exploitation-based credentials such as the OSCP (Offensive Security Certified Professional) and, for web application depth, the OSWE (Offensive Security Web Expert). These require candidates to compromise real systems under exam conditions, not just pass a multiple-choice test.
Red flag: a vendor that will not tell you who is testing, or that lists only company-level logos without naming any individual tester qualifications. Another warning sign is a proposal padded with certifications that are purely theoretical, with nothing practical behind them.
What a good answer sounds like: "Your lead tester holds OSCP and OSWE, here are their initials and we can verify on request, and here is their relevant healthcare experience." At Redfox Cybersecurity, engagements are staffed by testers with hands-on offensive certifications and healthcare experience, and we are happy to tell you who will be on your test before you commit.
General penetration testing skill does not automatically translate to healthcare. Ask how many healthcare engagements the firm has run, whether they understand PHI data flows, and whether they can map findings to the HIPAA Security Rule safeguards your compliance team needs. A tester who has worked on EHR integrations, patient portals, and clinical networks will find issues a generalist overlooks.
Red flag: vague claims of "experience across many industries" with no specific healthcare examples, or a team that cannot explain how a finding maps to 164.312 access control or the Breach Notification Rule.
What a good answer sounds like: a vendor that describes healthcare-specific testing, PHI data flow mapping, and reporting built around HIPAA safeguards. This is exactly the focus of our HIPAA penetration testing work, where every finding is tied to the relevant Security Rule requirement so your risk analysis and your auditor both get what they need.
This is the single most important question, because it is where quality varies most. Automated scanners are fast and useful for coverage, but they cannot find the flaws that cause most healthcare breaches: broken object-level authorization (IDOR), business logic flaws, chained privilege escalation, and authentication bypasses. Those require a human who understands the application. Ask what percentage of the engagement is manual, and ask them to describe a logic flaw a scanner would have missed.
Red flag: a "penetration test" priced suspiciously low and turned around in a day or two. That is almost always an automated scan with a report wrapper. Another red flag is a vendor that cannot clearly distinguish between a vulnerability scan and a penetration test.
What a good answer sounds like: a clear description of manual, attacker-driven testing against your specific application and environment, with scanning used only for breadth. Manual testing of authorization and business logic is the core of how our healthcare penetration testing engagements find the issues automated tools miss.
Finding vulnerabilities is only half the job. You need to know that your fixes actually work, and your auditor or customer will often want evidence that significant findings were remediated and verified. Ask whether a retest is included, how long after the initial test you have to use it, and whether the final report reflects the verified post-remediation state.
Red flag: retesting offered only as a costly add-on, or a hard deadline so short that your engineering team cannot realistically fix and reverify in time. A vendor uninterested in whether their findings get fixed is selling a document, not security.
What a good answer sounds like: a defined retest window included in the engagement, with an updated report or an attestation of remediation that you can hand to an auditor or customer.
The report is the deliverable. Before hiring, ask to see a sanitized sample, because the quality of that document tells you almost everything about the engagement behind it. A strong report includes a clear scope and methodology, an executive summary a non-technical leader can act on, detailed findings with reproduction steps and evidence, risk ratings that reflect real impact, developer-ready remediation guidance, and mappings to the frameworks you care about.
Red flag: a vendor that cannot produce a sample, or whose sample is a raw scanner export with CVSS scores and no context, no reproduction steps, and generic copy-paste remediation. If the sample does not map findings to HIPAA or to the Trust Services Criteria and you need that, it will not serve your compliance goals.
What a good answer sounds like: a sanitized sample you can read end to end, where even a complex finding is explained clearly enough for both an engineer and an executive to understand what to do next.
In healthcare, how a tester works is as important as what they find. Ask how they scope, how they handle systems that touch patient care, and what safeguards prevent disruption. A mature firm will discuss rules of engagement, testing windows, handling of production versus staging, and what happens if they encounter real PHI during testing.
Red flag: a vendor that is cavalier about testing production clinical systems, that has no clear rules of engagement, or that cannot explain how it avoids affecting availability. In healthcare, carelessness here can affect patient safety.
What a good answer sounds like: a documented scoping process, clear rules of engagement, a named emergency contact, and a described approach for minimizing any interaction with live clinical systems and for handling PHI encountered during testing.
A good engagement is a conversation, not a black box. Ask who your point of contact is, how critical findings are escalated mid-test, and whether you get a live readout at the end. If a tester finds a critical, actively exploitable flaw on day one, you want to hear about it immediately, not in a report three weeks later.
Red flag: no named contact, no plan for escalating critical findings during the test, and no debrief. Silence for the entire engagement followed by a PDF is a sign of a low-touch, low-effort process.
What a good answer sounds like: a named lead, an agreed channel for immediate escalation of critical findings, and a closing readout where your team can ask questions and plan remediation.
Some warning signs are serious enough to disqualify a vendor on their own. Watch for these across any healthcare penetration testing company you evaluate.
No legitimate tester guarantees you will "pass" an audit or that they will find nothing. Security is not pass or fail, and a vendor promising a clean result is either not testing seriously or is willing to misrepresent findings.
If the price and timeline only make sense for an automated scan, you are buying a scan. There is nothing wrong with vulnerability scanning, but it is not a penetration test, and presenting one as the other will not satisfy a serious auditor or protect you from a real attacker.
A firm handling your PHI-adjacent systems should carry professional and cyber liability insurance and should readily sign a Business Associate Agreement where appropriate. Reluctance here is a governance red flag.
Where your data and findings are stored and who has access matters under HIPAA. A vendor that cannot clearly explain where testing data lives and how it is protected is a risk to your compliance posture.
High-pressure sales, refusal to provide a written scope, or a quote that does not specify what will and will not be tested all point to problems you will feel later, usually when the auditor asks a question the test never covered.
Once you have asked the seven questions, comparing vendors becomes much easier. Put the answers in a simple matrix so you are comparing substance, not sales polish.
A digital health startup preparing for SOC 2 and HIPAA will weight deliverable quality and framework mapping heavily. A hospital with live clinical systems will weight safety, scoping, and communication. Decide your priorities before the sales calls so polish does not sway you away from substance.
If you want a reference point for what a thorough, healthcare-specific scope looks like, our healthcare penetration testing pages describe the methodology and coverage we bring to EHR integrations, patient portals, cloud environments, and clinical networks.
The evaluation runs both ways. A strong healthcare penetration testing company will ask you probing questions before quoting, because they cannot scope responsibly without them. Expect them to ask:
A vendor that quotes a fixed price without asking anything about your environment is guessing, and a guessed scope is usually either padded or dangerously thin. Thoughtful questions early are a sign you are dealing with professionals.
Knowing the shape of a good engagement helps you hold your chosen vendor to it. A well-run healthcare penetration test typically follows a clear arc: a scoping conversation and signed rules of engagement, a kickoff that confirms access and contacts, the testing window with mid-engagement escalation of anything critical, a draft report, a readout with your team, a remediation period, and a retest that verifies your fixes. You should finish with a report you can confidently hand to an auditor or a customer, and a clear understanding of your real risk.
If any stage is missing, for example there is no readout, or no retest, revisit whether the vendor is giving you a genuine assessment or just a document.
The right questions turn a confusing vendor comparison into a clear decision, and they protect you from paying for a test that would not have caught the attack that matters. If you are evaluating partners and want to see how a healthcare-focused, manual, HIPAA-mapped engagement would fit your environment, book a free scoping call with Redfox Cybersecurity. We are glad to answer all seven of these questions about our own team, and to walk through our HIPAA penetration testing and broader healthcare penetration testing services so you can compare us honestly against anyone else on your list.
Redfox Cyber Security Inc.
8 The Green, Ste. A,
Dover, Delaware 19901,
United States.
.avif)
